Health CanadaType II
NAT-Bendamustine: Discoloration
Published: December 6, 2022Recall ID: 72343Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
NAT-Bendamustine 100 mg/vial
Additional Source Details
| Field | Value |
|---|---|
| N I D | 72343 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/nat-bendamustine-discoloration |
| Issue | Product quality |
| Title | NAT-Bendamustine: Discoloration |
| Product | NAT-Bendamustine 100 mg/vial |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-12-06 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |